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Abstract
The term sepsis-associated encephalopathy (SAE) has been applied to animal models, postmortem studies in patients,
and severe cases of sepsis. SAE is considered to include all types of brain dysfunction, including delirium, coma, seizure,
and focal neurological signs. Clinical data for sepsis-associated delirium (SAD) have been accumulating since
the establishment of definitions of coma or delirium and the introduction of validated screening tools. Some
preliminary studies have examined the etiology of SAD. Neuroinflammation, abnormal cerebral perfusion, and
neurotransmitter imbalances are the main mechanisms underlying the development of SAD. However, there
are still no specific diagnostic blood, electrophysiological, or imaging tests or treatments specific for SAD. The
duration of delirium in intensive care patients is associated with long-term functional disability and cognitive impairment,
although this syndrome usually reverses after the successful treatment of sepsis. Once the respiratory and hemodynamic
states are stabilized, patients with severe sepsis or septic shock should receive rehabilitation as soon as possible because
early initiation of rehabilitation can reduce the duration of delirium. We expect to see further pathophysiological data and
the development of novel treatments for SAD now that reliable and consistent definitions of SAD have been established.
Keywords: Delirium, Coma, Acute brain dysfunction, Confusion Assessment Method for the Intensive Care Unit
(CAM-ICU), Intensive Care Delirium Screening Checklist (ICDSC), Sepsis-associated encephalopathy (SAE)
Introduction
The Pneumonia Severity Index, which was developed in
the USA, includes five key clinical factors: pulse rate,
respiratory rate, systolic blood pressure, body temperature,
and mental status [1]. Altered mental status was also cited
in the diagnostic criteria for sepsis proposed by Levy et al.
[2]. Mental confusion, rather than altered mental status,
was used to assess the severity of community-acquired
pneumonia in another study [3]. Although these studies
did not clearly define altered mental status or mental con-
fusion, these states may be indicative of delirium because
an acute change in mental status is a major feature of de-
lirium [4].
The American Psychiatric Association’s Fifth Edition
of the Diagnostic and Statistical Manual of Mental Disor-
ders (DSM-5) revised the diagnostic criteria for delirium
[5]. All states of altered arousal, except coma, are included
in the definition of delirium (Fig. 1). Delirium and coma
occurring in patients with critical illness are referred to as
acute brain dysfunction (Fig. 2) [6]. The terms septic
encephalopathy or sepsis-associated encephalopathy
(SAE) are often used in Japan. However, “delirium” is
used globally instead of“encephalopathy” in current
diagnostic manuals such as DSM-5 and the International
Classification of Diseases (ICD-10). In the present review,
we have used the terms sepsis-associated delirium (SAD)
or infectious delirium. SAD is considered a diffuse cerebral
dysfunction caused by the systemic inflammatory response
to an infection without evidence of a central nervous




The systemic inflammatory response is a key phenomenon
in critical illnesses and may progress to organ dysfunction,
including the brain. Systemic inflammation and endothelial
activation frequently occur during critical illnesses and
may augment cytokine transport across the blood–brain
barrier (BBB) [8], BBB disruption [9], and the infiltration of
leukocytes and cytokines into the central nervous system
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[10]. These events may result in ischemia and neuronal
apoptosis, which may present clinically as delirium [11].
These mechanisms have been investigated using animal
models [7, 12, 13] (Fig. 3).
Some recent clinical studies have sought to standardize
the detection of delirium in critically ill patients. In a pro-
spective cohort study [14], interleukin 6 (IL-6) concentra-
tions were higher in delirious patients than those in
comatose patients [14]. Another study revealed that, after
adjusting for covariates, lower plasma concentrations of
matrix metalloproteinase-9 (MMP-9) and protein C and
higher concentrations of soluble tumor necrosis factor
receptor-1 (sTNFR1) were associated with increased risk of
delirium [15]. These results suggest that inflammation and
coagulation may play important roles in the development
of delirium in patients with critical illness. We also assessed
delirium and obtained blood samples at two times: extuba-
tion (0 h) and 24 h after extubation (24 h) [16]. We found
that the serum concentrations of procalcitonin and IL-6
were significantly higher in the delirious patients than those
in the non-delirious patients at 24 h, but not at 0 h.
Crucially, these studies showed an association between the
onset of delirium and circulating biomarkers in critically ill
patients in both infectious and non-infectious conditions.
However, there are no clinical studies describing an associ-
ation between SAD (i.e., infectious delirium) and bio-
markers, even though much data have been accumulated in
animal models of sepsis [17, 18].
Two important studies have examined the association
between delirium and biomarkers in two different situa-
tions. The first study of intensive care unit (ICU) patients
with or without infection/systemic inflammatory response
syndrome (SIRS) revealed that IL-8 concentrations were
significantly associated with delirium in infected patients,
whereas the anti-inflammatory cytokine IL-10 and
amyloid β1-42/40 were associated with delirium in non-
infected patients [19]. The second study examined the
association between delirium and biomarkers in critically
ill patients with or without sepsis [20] and revealed that
plasma sTNFR1, sTNFR2, adiponectin, and IL-1β concen-
trations were higher in delirious patients than those in
non-delirious patients. However, sepsis did not modify the
associations between these biomarkers and the presence
of delirium.
Cerebral perfusion abnormalities
Several studies have measured cerebral perfusion in
patients with SAD. Pfister et al. [21] reported that SAD
was significantly associated with C-reactive protein




Fig. 1 Illustration of acute brain dysfunction (coma and delirium).
The sun represents the investigator. The sunbeam represents the
interview or tests (i.e., CAM-ICU) used to assess inattention. The
clouds (i.e., RASS score of ≤−4) represent cover on some levels of
arousal required to maintain cognition. RASS −3 the patient opens
their eyes or moves in response to a voice but does not make eye
contact. RASS −1 the patient is not fully alert but opens their eyes
and makes eye contact, which is sustained for more than 10 s in
response to a voice
Mild Severe 
Acute respiratory distress syndrome 
Severity 
Delirium Coma 
Acute brain dysfunction 
Moderate 
Fig. 2 The relationships between coma and delirium in contrast to
acute respiratory distress syndrome
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with IL-6 concentrations, and that elevated CRP was
significantly associated with disturbed autoregulation.
The impairments in cerebrovascular autoregulation
were subsequently investigated daily for 4 days after onset
in patients with severe sepsis or septic shock [22]. Auto-
regulation was impaired in 60 % of patients on day 1, 59 %
on day 2, 41 % on day 3, and 46 % on day 4. SAD was
present in 76 % of patients. Impaired autoregulation on
day 1 was also associated with the presence of SAD on
day 4. These results suggest that dysfunction of cerebral
autoregulation is a trigger for the development of SAD.
Impaired autoregulation might result in cerebral hypoper-
fusion or hyperperfusion, as well as SAD.
In another study, reduced vascular reactivity (as mea-
sured by peripheral artery tonometry) was associated
with a longer duration of delirium in a study of critically
ill patients, in which 30 % of patients had severe sepsis on
admission [23].
Neurotransmitter imbalances
Imbalances in several neurotransmitters, including the
dopamine, γ-aminobutyric acid (GABA), and acetylcholine
[24, 25] systems are also implicated in the etiology of delir-
ium. Dopamine increases the neuronal excitability, while
GABA and acetylcholine decrease neuronal excitability. An
imbalance in one or more of these neurotransmitters re-
sults in neuronal instability and unpredicatable neurotrans-
mission. Dopamine excess and acetylcholine depletion have
been associated with delirium. Several studies in non-ICU
settings have found a strong association between plasma
anticholinergic activity (PAA), a measure of cholinergic
blockade [26], and the development of delirium [27, 28].
Inflammation and cholinergic blockade, as measured by
serum CRP and PAA, respectively, were associated with
delirium in critically ill patients, and serum CRP and PAA
were correlated with each other [29]. Another study in
postoperative patients showed that the preoperative plasma
cholinesterase activity was correlated with the changes in
CRP and IL-6 concentrations after surgery in delirious
patients [30]. Delirium was associated with impaired inter-
actions between the cholinergic and immune systems.
However, prophylactic, short-term administration of oral
rivastigmine, a cholinesterase inhibitor, did not reduce the
incidence of delirium in elderly patients for up to 6 days
after elective cardiac surgery [31]. Therefore, owing to the
multifactorial pathophysiology of delirium, interventions
that only target the cholinergic system might be insuffi-
cient to prevent delirium.
Diagnosis of SAD
Delirium screening tools
The 2013 American College of Critical Care Medicine
(ACCM)/Society of Critical Care Medicine (SCCM) clinical
practice guidelines for pain, agitation, and delirium (PAD)
recommend that critically ill patients should undergo rou-
tine monitoring for the onset of delirium in the ICU using
a validated tool [32]. The Confusion Assessment Method
for the Intensive Care Unit (CAM-ICU) [33] and the In-
tensive Care Delirium Screening Checklist (ICDSC) [34]
are the most valid and reliable tools for monitoring delir-
ium in adult ICU patients [32].
The CAM-ICU, which was derived from DSM-4
criteria, evaluates four features of delirium: (1) acute
changes or fluctuations in mental status from baseline,
(2) inattention, (3) altered consciousness, and (4) disorga-























Fig. 3 The mechanism of sepsis-associated delirium. Double-lined boxes correspond to the clinical evidence reported in the main text. SIRS systemic
inflammatory response syndrome, ROS reactive oxygen species, NO nitric oxide
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exhibits features 1 and 2 and either of features 3 or 4. Pa-
tients are defined as comatose if they respond only to phys-
ical/painful stimulation with movement but do not open
their eyes (Richmond Agitation–Sedation Scale (RASS)
[35] score, −4) or if they do not respond to verbal or phys-
ical stimuli (RASS score, −5) (Fig. 1). Delirium is defined as
a response to verbal stimulation with eye opening (RASS
score of −3 to +4) and a positive CAM-ICU value [4].
A change in the RASS score from −3 (the patient opens
their eyes or move in response to a voice but does not make
eye contact) to −4, a transition from delirium to coma, may
be part of the continuum of progressively smaller levels of
arousal. Alternatively, does this transition indicate a funda-
mental change in the pathophysiology of the acute brain
dysfunction? [36]. The widespread administration of
sedatives during mechanical ventilation of septic pa-
tients further complicates our understanding of acute
brain dysfunction in such patients [36]. Subsequently,
Patel et al. classified delirium into two categories: sedation-
related delirium (delirium that abates shortly after sedative
interruption) and persistent delirium [37]. After interrupt-
ing the patients’ sedatives, the investigator assessed whether
the patients could follow four commands (squeeze the in-
vestigator’s hand, open their eyes, track an object with their
eyes, or stick out their tongue) [38]. Patients who could not
follow these commands after 2 h were classified as having
persistent delirium. It was reported that the 1-year mortal-
ity rate was greater in patients with persistent delirium than
that in patients without delirium or with sedation-related
delirium [37]. In some studies, delirium was defined as a
RASS score of >−3 [39] or >−2 [22].
The ICDSC, which is also derived from DSM-4 criteria,
evaluates eight features of delirium: (1) altered conscious-
ness; (2) inattention; (3) disorientation; (4) hallucinations,
delusions, or psychoses; (5) psychomotor agitation or re-
tardation; (6) inappropriate speech or mood; (7) disturbed
sleep/wake cycles; and (8) symptom fluctuations [34]. The
ICDSC, which incorporates the assessment of each feature
over the course of the nursing shift, should not be used in
heavily sedated patients (i.e., RASS score of ≤−4). The
ICDSC is assessed based on the observations over the pre-
ceding 24 h. A total score of ≥4 denotes the presence of
delirium, while total scores of 1–3 denote subsyndromal
delirium [40]. The ICU mortality rates were 2.4, 10.6, and
15.9 % in patients without delirium, patients with subsyn-
dromal delirium, and patients with delirium, respectively,
defined according to ICDSC scores [40]. Therefore, the
ICDSC allows ICU specialists to detect subsyndromal de-
lirium, which is associated with intermediate adverse
outcomes.
Electrophysiological testing
Electrophysiological testing and neuroimaging are not
always needed for the diagnosis of acute brain dysfunction
or delirium in septic patients (Fig. 4). These tests should
be considered in patients with persistent coma or delirium
despite improvements in the functions of other organs
and if the sedatives have been washed out.
The results of electroencephalograms (EEGs) are classi-
fied by severity based on the predominant waveform, in-
cluding excessive θ, predominant δ, or triphasic waves,
and suppression or burst suppression [41]. One study in-
vestigated the diagnosis of SAD by the CAM-ICU and the
predominant EEG features on day 4 after a reduction of
sedation to a RASS score of >−2 [22]. The authors re-
ported that the diagnosis of SAD was not associated with
EEG abnormalities. Furthermore, cerebrovascular autoreg-
ulation was not associated with EEG abnormalities.
Hosokawa et al. conducted a systematic review of EEG
abnormalities in patients diagnosed with SAE or sepsis-
associated brain dysfunction (SABD) [42]. The diagnos-
tic methods were not reported in the systematic review
and 5/17 studies were conducted before the introduction
of the CAM-ICU and ICDSC in 2001. It is possible that
SAE and SABD include coma and/or delirium in septic
patients. The incidence of EEG abnormalities in septic
patients ranged from 12 to 100 % for background abnor-
malities and from 6 to 12 % for triphasic waves. The
authors concluded that EEG is a sensitive tool for the de-
tection and diagnosis of SAE/SABD. A slowing of the
normal α rhythm coinciding with the appearance of θ activ-
ity occurs in patients without evidence of encephalopathy
and in patients with mild to moderate encephalopathy
(e.g., confusion and delirium) and therefore reflects
cortical dysfunction. More severe states of altered con-
sciousness (e.g., stupor and coma) are associated with
greater slowing together with increased δ activity, triphasic
waves, and the more malignant burst suppression patterns
that indicate impaired function of deeper brain structures,
such as the basal ganglia and the diencephalon.
One study has sought to differentiate between coma and
delirium in septic shock patients [43]. Coma was defined as
a Glasgow Coma Scale (GCS) score of <8 in non-sedated
patients or at 3 days after discontinuing sedation in previ-
ously sedated patients. Delirium was evaluated using the
CAM-ICU. EEGs were analyzed using the Synek 5-point
scale [44]. The median EEG grade was 3.5 (range 3.0–4.0)
in coma and 3.0 (range 1.0–3.5) in delirium. An EEG grade
of >3 was significantly more frequent in patients who died.
Compared with EEG, few studies have investigated sen-
sory evoked potentials (SEP) in sepsis. The peak latency
was significantly longer in patients with severe sepsis or
septic shock than that in healthy controls, and it was cor-
related with the severity of sepsis [45]. However, the peak
latency was not significantly different between patients
with severe sepsis and those with septic shock. Although
no studies have measured SEP in patients with SAD, a
benefit of SEP is that it is not affected by sedation.
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Neuroimaging
Brain computed tomography (CT) is often performed
when septic patients display sudden changes in arousal
or mental status, or persistent coma or delirium is unex-
plained by sedation. CT scans provide some information
to aid the differential diagnosis, including focal brain in-
fection, bleeding, and air embolism.
Magnetic resonance imaging (MRI) provides better
and earlier information on brain damage, especially of
the white matter and BBB. In a prospective study of 71
patients with septic shock, ischemic stroke and leukoen-
cephalopathy were the two most frequent lesions [43].
Sharshar et al. hypothesized that leukoencephalopathy
reflects BBB changes and identified it neuropathologi-
cally in a patient with diffuse leukoencephalopathy [46].
They also showed that an EEG grade of >3, as defined
by Synek’s scale [44], was correlated with the presence of
ischemic stroke or leukoencephalopathy on MRI in coma-
tose or delirious patients. Therefore, they recommended
that EEG should be done continuously or every day before
MRI because of the risk of transport from the ICU to the
MRI suite.
Treatment of SAD
There are still no specific treatments for SAD. The treat-
ment options for severe sepsis and septic shock are de-
scribed in established guidelines [47], which recommend
that continuous or intermittent sedation should be limited
in mechanically ventilated septic patients and that the
treatments should target specific titration endpoints. An a
priori subgroup analysis of the Maximizing Efficacy of
Targeted Sedation and Reducing Neurological Dysfunc-
tion (MENDS) study revealed that septic patients treated
with dexmedetomidine had more days free of delirium
than patients treated with a lorazepam-based sedation
regimen [48]. However, lorazepam infusion is not available
and dexmedetomidine at doses >0.7 μg/kg/h is not per-
mitted in Japan.
Interestingly, two clinical trials have examined the
association between stain use in an ICU and delirium in
critically ill patients [49, 50]. Statins have pleiotropic
effects on inflammation and coagulation. In the first
study, statin exposure was independently associated
with 2.28 times greater odds of being free of delirium
[49]. In the second study, in which 55 % of patients
had sepsis on day 1, statin exposure was associated
with reduced risk of delirium among patients with sepsis
on day 1 but not among patients without sepsis on day 1
[50]. A phase 2, randomized, placebo-controlled trial in-
vestigating whether simvastatin can reduce the risk of de-
lirium in mechanically ventilated critically ill patients is
ongoing (ISRCTN89079989).
Early physical and occupational therapy in mechanically
ventilated patients, of whom 14 % had sepsis, decreased the
number of days with delirium to half of that in the control
group, even though the sedation regimen was identical in
both groups (median 2 vs 4 days) [51]. Patients with severe
sepsis or septic shock who display improvements and
stabilization of their respiratory and hemodynamic states
should receive rehabilitation as soon as possible. Delirium
associated with sepsis or other causes was an independ-
ent predictor of the 6-month mortality rate [4], and the
Patients in sepsis













As needed, EEG, SEP, CT, MRI
Fig. 4 Diagnostic decision tree for acute brain dysfunction and sepsis-associated delirium (SAD). RASS Richmond Agitation–Sedation Scale, EEG
electroencephalogram, SEP sensory evoked potential, CT computed tomography, MRI magnetic resonance imaging
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duration of delirium in the ICU was associated with
long-term functional disability [52] and cognitive im-
pairment [53, 54]. Furthermore, a cohort study revealed
that severe sepsis was independently associated with
persistent cognitive and functional limitations [55]. The
risk of moderate to severe cognitive impairment tripled
in septic patients. Taken together, these findings indicate
that cognitive and physical rehabilitation is essential and
should be initiated as soon as possible in the ICU and con-
tinued for as long as possible after discharge from the ICU.
Conclusions
The pathogenesis of SAD (infectious delirium) and the
features of this disorder in vivo are still unclear. Sys-
temic inflammation and endothelial activation are com-
mon in critical illnesses and are associated with central
nervous system disorders that may present clinically as
delirium. Studies of patients with SAD have increased
since the development of validated and reliable screen-
ing tools for delirium. However, when interpreting these
studies, we should carefully assess their definitions of
coma or delirium in septic patients. Finally, we believe
that blood biomarkers, cerebrovascular autoregulation,
electrophysiological, and neuroimaging tests are necessary
in septic patients to establish consistent, pan-institutional
definitions of coma/delirium.
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